Memorial Day Sale – Claim 70% Off TipRanks

• Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
• Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter

The latest announcement is out from Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H ( (HK:1858) ).

Beijing Chunlizhengda Medical Instruments Co., Ltd., a PRC-based medical instruments manufacturer listed in Hong Kong and on the mainland A-share market, convened its 2025 annual general meeting and an A-shareholders’ class meeting in Beijing. The meetings were organized by the board, chaired by Ms. Shi Wenling, and complied with PRC law, Hong Kong listing rules and the company’s articles, with voting conducted through a mix of online and on-site poll procedures.

Shareholders voted on resolutions using 382,191,649 eligible shares at the AGM and 287,051,149 eligible A shares at the class meeting, excluding treasury shares from voting rights. Controlling shareholders and executives Mr. Shi Chunbao and Ms. Yue Shujun abstained from voting on one resolution as required, while all directors attended in person or by phone, underscoring adherence to governance and regulatory requirements for stakeholder decision-making.

More about Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H

Beijing Chunlizhengda Medical Instruments Co., Ltd. is a PRC-incorporated medical device maker listed in Hong Kong as an H-share company. It operates in the orthopedic and broader medical instruments sector, serving both A-share and H-share investors through dual listings on mainland China and the Hong Kong Stock Exchange.

Average Trading Volume: 891,607

Technical Sentiment Signal: Sell

Current Market Cap: HK$6.49B

For an in-depth examination of 1858 stock, go to TipRanks’ Overview page.